Detalles de la búsqueda
1.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med
; 384(22): 2102-2114, 2021 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34077643
2.
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Future Oncol
; 19(6): 413-426, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919916
3.
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
Jpn J Clin Oncol
; 53(1): 16-25, 2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300304
4.
Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. Reply.
N Engl J Med
; 385(10): 957, 2021 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34469656
5.
Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.
Int J Clin Oncol
; 24(9): 1089-1098, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31218529
6.
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
N Engl J Med
; 373(4): 317-27, 2015 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26200978
7.
Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061.
Oncology
; 90(1): 21-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26468947
8.
A risk management approach for imaging biomarker-driven clinical trials in oncology.
Lancet Oncol
; 16(16): e622-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26678215
9.
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Lancet Oncol
; 16(1): 47-56, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25500422
10.
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial.
Eur J Nucl Med Mol Imaging
; 42(6): 848-57, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25711176
11.
Concordance measures in shared frailty models: application to clustered data in cancer prognosis.
Stat Med
; 32(27): 4803-20, 2013 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-23729305
12.
Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response.
Clin Cancer Res
; 29(1): 143-153, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302172
13.
Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score.
Eur Urol
; 83(5): 432-440, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868932
14.
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275.
Clin Cancer Res
; 26(19): 5120-5128, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532789
15.
Reply to 'interpretation of concordance measures for clustered data'.
Stat Med
; 33(4): 717-8, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24425542
16.
Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial setting.
Eur J Cancer
; 114: 89-96, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31078973
17.
Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 5(2): 243-247, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30419088
18.
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial.
JAMA Oncol
; 5(2): 164-170, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30543350
19.
Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME).
Eur Urol
; 76(4): 437-440, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227307
20.
Corrigendum to "Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score" [Eur. Urol. 83(5) (2024) 432-440].
Eur Urol
; 85(3): e96-e97, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38176992